Keywords: fda, tells, pfizer, pull, bextra, off, market

FDA tells Pfizer to pull Bextra off market, add warning to Celebrex

Article | 11 April 2005

Print This

In a move that seems to sound the death-knell for COX-2 inhibitor arthritis drugs, world drug leader Pfizer says that ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in